Skip to content

Posts tagged ‘New Products’

What's hot at AACR 2011? Watch PSB Films

April 1st, 2011

Daedalus

We are excited to hear that Sally Church has produced another video to follow on from her recent video debut on Pharma Strategy Blog.

Produced by the aptly named, “PSB Films”, it is a trailer for her eagerly awaited post on “What’s hot at AACR 2011?”

Readers of Sally’s blog will know that prior to major scientific meetings such as AACR, ASCO and ASH, Sally often provides a mixture of commentary and insight on what she predicts will be hot topics.

Happy April 1st!

 

 

Genomics and Cancer Research

January 27th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

Since the human genome was sequenced in 2000, much progress has been made with cancer research.  In a review article published this week in the New England Journal of Medicine, McDermott et al., (2011), provide insight on what has taken place and what the future may hold.

Click here to read the full post on Pharma Strategy Blog

Why does sorafenib work in HCC but sunitinib does not?

January 24th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

Using SpringPad as a CRM in Pharma Consulting

January 12th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

Innovation in Healthcare Symposium

January 12th, 2011

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Impact of the Supreme Court case on adverse events including cancer

January 11th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

New advances in triple negative breast cancer

January 10th, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog

New research points to role of Cystic Fibrosis Transmembrane Conductance Regulator Signaling in Emphysema

January 10th, 2011

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Icarus Consultants to attend ISGC Meeting in Houston

January 4th, 2011

Daedalus

Sally Church, PhD will be attending the 6th International Society of Gastroenterological Carcinogenesis (ISGC) meeting in Houston from Thursday 6th to Saturday, 8th January, 2011. Hosted by the MD Anderson Cancer Center, the meeting has an impressive line up of key opinion leaders. Further information can be found on the Pharma Strategy Blog.

Glioblastoma recurrence after VEGF therapy

January 3rd, 2011

Daedalus

Published by Sally Church on Pharma Strategy Blog